Use of GLP-1 compound for treatment of critically ill patients
- 专利权人:
- Lotte Bjerre Knudsen;Johan Selmer;Kristian Tage Hansen
- 发明人:
- Lotte Bjerre Knudsen,Johan Selmer,Kristian Tage Hansen
- 申请号：
- US12496910
- 公开号：
- US08088731B2
- 申请日:
- 2009.07.02
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- Use of medicament for life saving treatment of critically ill patients and method of treatment. The medicament comprises a GLP-1 compound which effectively controls the blood glucose level.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION FOR USE IN DECREASING BLOOD GLUCOSE LEVELS OR IN THE PREVENTION OR TREATMENT OF DIABETES
- A BIODEGRADABLE MICROSPHERE COMPOSITION SUITABLE FOR THE CONTROLLED RELEASE OF GLUCOSE CONTROLLING PEPTIDE AND FORMULATION THEREOF
- Polypeptides used in the treatment of metabolic diseases and their compositions
- Peptides derived from RS1 that down-regulate glucose inhalation and increase insulin sensitivity after a glucose-rich diet
- Composition for Preventing or Treating Insulin Resistance or Insulin Resistance-Related Diseases Comprising Eleutheroside E
